Shire PLC operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Shire PLC with three other
pharmaceutical manufacturers in Europe:
sales of 3.88 billion Euro [US$4.22 billion]
of which 100%
Lonza Group AG
(3.80 billion Swiss Francs [US$3.83 billion]
of which 57%
was Specialty Ingredients), and
Protek OAO (P)
based in Russia
(195.31 billion Russian Rubles [US$3.14 billion]
of which 81%
During the year ended December of 2015, sales at
Shire PLC were £4.21 billion (US$5.15 billion).
increase of 15.0%
versus 2014, when the company's sales were £3.66 billion.
This was the fifth consecutive year of sales increases at Shire PLC
(and since 2010, sales have increased a total of 88%).